Gunnar Wahlberg
Corporate Officer/Principal bei IDL BIOTECH AB
Aktive Positionen von Gunnar Wahlberg
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IDL BIOTECH AB | Corporate Officer/Principal | - | - |
| Vorstandsvorsitzender | - | - | |
| Vertrieb & Marketing | 01.01.2019 | - | |
| AROCELL AB | Vertrieb & Marketing | 01.01.2021 | - |
Karriereverlauf von Gunnar Wahlberg
Statistik
International
| Schweden | 3 |
Operativ
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AROCELL AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
IDL Biotech AB
 IDL Biotech AB Medical SpecialtiesHealth Technology IDL Biotech AB engages in the development, production and marketing of in vitro diagnostic tests for the healthcare sector. The firm is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. Its products include TPS, TPAcyk, UBC, Monototal, and Tubex. The company was founded in 1988 and is headquartered in Bromma, Sweden. | Health Technology |
- Börse
- Insiders
- Gunnar Wahlberg
- Erfahrung
